We are live on ! Find out more
FUSN

Fusion Pharmaceuticals Inc. Common Shares
FUSN

Delisted

FUSN was delisted on the 3rd of June, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Fusion Pharmaceuticals Inc. Common Shares in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 112 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 114 → 0 (-114)

100% less funds holding in top 10

Funds holding in top 10: 8 → 0 (-8)

100% less capital invested

Capital invested by funds: $1.47B → $0 (-$1.47B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 112

Holders
–
Holders Change
-114
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
112
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$230M
2
PA
Perceptive Advisors
New York
-$146M
3
APM
Avidity Partners Management
Texas
-$139M
4
DM
Deerfield Management
New York
-$136M
5
Fidelity International
Fidelity International
Bermuda
-$89.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
– -$230M -10,811,153 Closed
PA
2
Perceptive Advisors
New York
– -$146M -6,825,395 Closed
APM
3
Avidity Partners Management
Texas
– -$139M -6,500,328 Closed
DM
4
Deerfield Management
New York
– -$136M -6,401,000 Closed
Fidelity International
5
Fidelity International
Bermuda
– -$89.3M -4,187,271 Closed
PCM
6
Pentwater Capital Management
Florida
– -$80.6M -3,781,778 Closed
JJ
7
Johnson & Johnson
New Jersey
– -$78.3M -3,670,516 Closed
Canada Pension Plan Investment Board
8
Canada Pension Plan Investment Board
Ontario, Canada
– -$66.5M -3,116,966 Closed
TGA
9
TPG GP A
Texas
– -$54.4M -2,551,794 Closed
Fidelity Investments
10
Fidelity Investments
Massachusetts
– -$39.2M -1,836,739 Closed
Millennium Management
11
Millennium Management
New York
– -$34.3M -1,608,882 Closed
Marshall Wace
12
Marshall Wace
United Kingdom
– -$32M -1,501,283 Closed
TAL
13
TIG Advisors LLC
New York
– -$21.4M -1,003,628 Closed
Qube Research & Technologies (QRT)
14
Qube Research & Technologies (QRT)
United Kingdom
– -$21M -987,178 Closed
William Blair & Company
15
William Blair & Company
Illinois
– -$16.6M -779,202 Closed
1832 Asset Management
16
1832 Asset Management
Ontario, Canada
– -$15.7M -734,321 Closed
Walleye Capital
17
Walleye Capital
New York
– -$14M -657,385 Closed
Jane Street
18
Jane Street
New York
– -$13.5M -633,932 Closed
JP Morgan Chase
19
JP Morgan Chase
New York
– -$12.9M -605,742 Closed
AAM
20
Alpine Associates Management
Florida
– -$12.5M -585,102 Closed
EHI
21
Eagle Health Investments
Connecticut
– -$12.4M -579,769 Closed
PBPIA
22
Pivotal bioVenture Partners Investment Advisor
California
– -$12M -563,385 Closed
BlackRock
23
BlackRock
New York
– -$11M -516,795 Closed
SGCM
24
Sand Grove Capital Management
United Kingdom
– -$10.5M -490,547 Closed
Balyasny Asset Management
25
Balyasny Asset Management
Illinois
– -$10.4M -486,971 Closed
1
2 3 4 5

FUSN Hedge Fund Activity: Q2 2024 in Review

0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Fusion Pharmaceuticals Inc. Common Shares (FUSN) for Q2 2024, worth a combined $0 — down 100% from $1.47B a quarter earlier.

Sellers outnumbered buyers: 112 funds closed out of FUSN and 0 opened new positions — a net loss of 112 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Federated Hermes, exiting entirely with an estimated $230M sold.

  • 0 institutional investors held Fusion Pharmaceuticals Inc. Common Shares (FUSN) as of Q2 2024, down from 114 in Q1 2024.
  • Funds reported $0 of Fusion Pharmaceuticals Inc. Common Shares stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Fusion Pharmaceuticals Inc. Common Shares positions in Q2 2024 and 112 closed out, a net change of -112 holders.
  • The largest Fusion Pharmaceuticals Inc. Common Shares seller in Q2 2024 was Federated Hermes, an estimated $230M sold.

Based on aggregated 13F filings for Q2 2024.